Oncolysate

An extract made from cancer cells.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1967-2017
024619672017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
We demonstrated before that primary operated breast cancer patients contain in their bone marrow (BM) cancer reactive memory T… (More)
Is this relevant?
1998
1998
BACKGROUND The development of effective adjuvant therapies for the treatment of high-risk melanoma patients is critical for the… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1998
1998
BACKGROUND A phase III, randomized, double-blind, multicenter trial of active specific immunotherapy (ASI) using vaccinia… (More)
Is this relevant?
1995
1995
BACKGROUND In a Phase II trial, surgical adjuvant active specific immunotherapy using a live vaccinia virus-augmented allogeneic… (More)
Is this relevant?
1992
1992
Newcastle disease virus oncolysate was examined as an adjunctive immunotherapeutic agent in the postsurgical management of 83… (More)
Is this relevant?
1987
1987
In this phase Ia/Ib trial, vaccinia melanoma oncolysate (VMO) is a virus-augmented melanoma cell membrane vaccine that has been… (More)
Is this relevant?
1986
1986
Five patients with advanced malignant melanoma, treated with viral oncolysate, had solitary central nervous system metastases… (More)
Is this relevant?
1983
1983
A Newcastle disease virus lysate of malignant melanoma cells was examined for its possible value in delaying the progression of… (More)
Is this relevant?
1977
1977
Melanoma cell oncolysate, prepared with Newcastle disease virus, was administered as an immunostimulant to 13 patients with… (More)
Is this relevant?
1977
1977
Primary explants of human malignant melanoma were utilized in the preparation of oncolysates by Newcastle disease virus. The… (More)
Is this relevant?